410 related articles for article (PubMed ID: 28457336)
1. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
2. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
3. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.
Sonnenday CJ; Dimick JB; Schulick RD; Choti MA
J Gastrointest Surg; 2007 Dec; 11(12):1636-46; discussion 1646. PubMed ID: 17912593
[TBL] [Abstract][Full Text] [Related]
4. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
5. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
6. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study.
Beutler BD; Ulanja MB; Krishan R; Aluru V; Ndukwu ML; Hagen MM; Dupin ZD; Willyard CE; Moody AE; Boampong-Konam K; Zell SC
Cancer Control; 2020; 27(1):1073274820956615. PubMed ID: 32951450
[TBL] [Abstract][Full Text] [Related]
8. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
9. Birth cohort-specific disparities in hepatocellular carcinoma stage at diagnosis, treatment, and long-term survival.
Yan M; Ha J; Aguilar M; Bhuket T; Liu B; Gish RG; Cheung R; Wong RJ
J Hepatol; 2016 Feb; 64(2):326-332. PubMed ID: 26386160
[TBL] [Abstract][Full Text] [Related]
10. Older Patients With Hepatocellular Carcinoma Have More Advanced Disease, Lower Rates of Treatment, and Lower Survival.
Yan M; Ha J; Aguilar M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2017 Apr; 51(4):378-383. PubMed ID: 27380460
[TBL] [Abstract][Full Text] [Related]
11. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
Mironov O; Jaberi A; Kachura JR
J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
[TBL] [Abstract][Full Text] [Related]
12. Approximately one-half of patients with early-stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post-MELD exception era.
Devaki P; Wong RJ; Marupakula V; Nangia S; Nguyen L; Ditah IC; Ehrinpreis MN; Nguyen MH
Cancer; 2014 Jun; 120(11):1725-32. PubMed ID: 24590359
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
Siegel AB; McBride RB; El-Serag HB; Hershman DL; Brown RS; Renz JF; Emond J; Neugut AI
Am J Gastroenterol; 2008 Jan; 103(1):120-7. PubMed ID: 18005365
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis.
Lee GC; Ferrone CR; Vagefi PA; Uppot RN; Tanabe KK; Lillemoe KD; Blaszkowsky LS; Qadan M
Am J Surg; 2019 Jul; 218(1):157-163. PubMed ID: 30635211
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
16. Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type.
Zak Y; Rhoads KF; Visser BC
Arch Surg; 2011 Jul; 146(7):778-84. PubMed ID: 21422327
[TBL] [Abstract][Full Text] [Related]
17. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
18. Associations of Socioeconomic Variables With Resection, Stage, and Survival in Patients With Early-Stage Pancreatic Cancer.
Shapiro M; Chen Q; Huang Q; Boosalis VA; Yoon CH; Saund MS; Whang EE; Gold JS
JAMA Surg; 2016 Apr; 151(4):338-45. PubMed ID: 26581025
[TBL] [Abstract][Full Text] [Related]
19. Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):861-866. PubMed ID: 31953780
[TBL] [Abstract][Full Text] [Related]
20. Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment.
Ziogas IA; Ye F; Zhao Z; Matsuoka LK; Montenovo MI; Izzy M; Benedetti DJ; Lovvorn HN; Gillis LA; Alexopoulos SP
J Am Coll Surg; 2020 Jun; 230(6):1035-1044.e3. PubMed ID: 32272204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]